xCures Unveils Expanded AI Health Data Platform: Now Supporting All Therapeutic Areas and is Available as SaaS
The company’s platform expansion transforms the value of US healthcare data by harnessing real-time, regulatory-grade data in any therapeutic area to efficiently understand the complex medical histories of patients and drive research through detailed, longitudinal datasets. OAKLAND, CA – January 31, 2024 – xCures, a trailblazer in healthcare technology, announced today the expansion of its […]
xCures and Aetion® Further Enhance Partnership with Rich Real-World Datasets
Partnership now includes access to five comprehensive oncology datasets, enhancing real-world evidence in cancer research. In the realm of oncology research, diverse, comprehensive, and fully longitudinal datasets are invaluable. They offer a granular view of patient journeys throughout the US, enabling researchers to draw clinically relevant insights. These comprehensive datasets are crucial for advancing personalized […]
xCures to offer clinical data extraction as a service in AWS Marketplace
AWS cloud configurations will help xCures customers to leverage the company’s robust data gathering and structuring services while maintaining secure, private ownership of their data. xCures, a trailblazer in healthcare technology is proud to offer its platform as a clinical data extraction service in AWS Marketplace, a digital catalog with thousands of software listings from […]
xCures Partners with the Pancreatic Cancer Action Network (PanCAN)
xCures offers unparalleled access to data and the xINFORM patient portal to accelerate pancreatic cancer research and improve patient care OAKLAND, CA – xCures, a leader in real-time clinical data technology, is thrilled to announce a pivotal partnership with the Pancreatic Cancer Action Network (PanCAN). As part of the agreement, PanCAN’s researchers and grantees will […]
xCures Platform advances progress on the White House Cancer Moonshot mission to end cancer as we know it.
New study will collect, organize, and share data for Diffuse Midline Glioma (DMG) and Diffuse Intrinsic Pontine Glioma (DIPG) research. xCures, a leader in data-driven cancer solutions, is thrilled to announce that its platform has been highlighted as a new commitment to deliver progress on the mission of the White House Cancer Moonshot – ending […]
xUTILITY to Lead the Way Integrating Research and Patient Care
Seamless integration with existing healthcare infrastructures drives unprecedented possibilities to improve medical research and patient care. xCures, a trailblazer in healthcare technology, is delighted to unveil xUTILITY, a solution poised to transform the patient registry paradigm in the United States. xUTILITY establishes an instantaneous patient registry platform by retrieving records nationwide and automatically digitizing and […]
xCures to Contribute Data to Support Aetion®’s Collaboration with FDA
xCures data deemed fit-for-purpose to address research questions relevant to the prevention, clinical care, diagnostics, and treatment in oncology. First posted on NewsDirect In a step forward for healthcare research, xCures is pleased to announce that it will support Aetion®’s collaboration with the US Food and Drug Administration (FDA) Oncology Center of Excellence (OCE). As […]
xCures and DDRFA partner to make an impact on patient-driven DIPG & DMG research
xCures’ technology harnesses real-time patient data and makes it accessible for scientific exploration and to improve patient options. Today, xCures and the Diffuse Intrinsic Pontine Glioma (DIPG) / Diffuse Midline Glioma (DMG) Research Funding Alliance (DDRFA) are proud to announce their partnership, a collaboration focused on leveraging real-time patient data to drive forward DMG (including […]
CureMatch and xCures Partner to Revolutionize the Standard for Precision Cancer Treatment Processes
CureMatch will leverage the xCures technology that automatically creates a comprehensive outline of a cancer patient’s medical history in order to improve treatment recommendations. CureMatch, Inc., a healthcare technology company that leverages artificial intelligence (AI) to power precision medicine support for oncology, is proud to announce a partnership with xCures, Inc., to connect cancer patients […]
xCures showcases the power of its real-time clinical data platform at ASCO Annual Meeting 2023
Real-world patient data gives valuable insights, such as collecting data on rare cancers and showing real-world side effects of treatment combinations. [Oakland, CA, May 26, 2023] – xCures, a healthcare technology company, is pleased to announce its participation at the American Society of Clinical Oncology (ASCO) Annual Meeting 2023, to be held from June 02 […]
Genome Medical and xCures Partner to Enhance Genetic Services with Personalized Clinical Data
Genome Medical and xCures have joined forces to provide patients with a new level of personalized care. Through this collaboration, Genome Medical’s genetic counselors will have access to xCures’ comprehensive care summaries for patients based on electronic medical records from across the healthcare ecosystem. This information will be used to better inform the treatment of […]
xCures partners with RenovoRx to assist patients in accessing RenovoRx’s TIGeR-PaC study
RenovoRx’s Phase III clinical study is open to pancreatic adenocarcinoma patients and focuses on extending overall survival and improving quality of life. [EINPresswire] xCures, Inc. is proud to announce their partnership with RenovoRx, a clinical-stage biopharmaceutical company that focuses on fighting cancer through localized treatment of difficult-to-treat tumors, such as pancreatic adenocarcinoma. Through this collaboration, […]
xCures Joins Big Names in Aetion’s New Initiative
xCures, a Real-Time Regulatory Grade Clinical Data (RRC) platform, will be joining Aetion, a global real-world evidence software and analytics provider, and a group of leading diverse partners in Aetion’s launch of the Coalition for the Advancement of RWE through Randomized Controlled Trial Emulation (CARE) Initiative. Aetion’s initiative will focus on better understanding the regulatory questions that […]
xCures presents clinical and translational research with two posters at the 2022 SNO Annual Meeting
XCELSIOR registry showcases its power in using real-world datasets and clinical outcomes to aid decision-making and treatment options for CNS cancer patients. [EIN Presswire] Today, xCures announced that they will present two posters at the 27th Annual Meeting of the Society for Neuro-Oncology, from the 16th to the 20th of November 2022, in Tampa Bay, […]
Finally, cancer patients have real-time access to their medical records
Recent changes to patients’ data rights enable xCures’ platform to automatically retrieve patient medical records from institutions and generate powerful care summaries. EINPressWire, 11/8/22 Last month, the 21st Century Cures Act forced healthcare organizations to provide patients quick and easy access to their health records in a digital format. In response to the news, xCures […]
xCures and mProbe partner to help cancer patients determine optimal treatments
xCures partners with mProbe, to leverage their targeted proteomics platform for profiling individual patients’ cancer tissues for actionable drug targets xCures, Inc. is proud to announce their collaboration with mProbe Inc., a premier CLIA-certified targeted proteomics company. mProbe utilizes a proprietary technology platform integrating artificial intelligence and multi-omic diagnostics to transform the diagnosis, prevention, and […]
xCures and Oblato announce the launch of a Compassionate Use program for OKN-007
Oblato’s first-in-class small molecular OKN-007 will be available through a newly opened compassionate use protocol. xCures, Inc., a clinical study platform provider, and Oblato, Inc., a biotechnology company, are pleased to announce the availability of OKN-007 through an intermediate size expanded access program (iEAP) for eligible patients with pediatric diffuse midline glioma (DMG), inclusive of […]
Pancreatic Cancer Patients Will Now Have Remote Access to Precision Nutrition Trial Through New Partnership
xCures and Vault Health integration creates a decentralized platform to benefit pancreatic cancer research and facilitate enrollment in Faeth’s NEAAR-001 study xCures, Inc. is proud to partner with Vault Health, a decentralized research and workforce screening company, to facilitate the enrollment of pancreatic cancer patients in Faeth Therapeutics’ NEAAR-001 research study. NEAAR-001 is a clinical trial […]